Ce Rick Strattan Cyclo Therapeutics, Inc. (CYTH) insider trading activity

CYTH Quotes by TradingView

Ce Rick Strattan is Director of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 305,495 shares of CYTH, which is worth approximately $195,516. The most recent transaction as insider was on Aug 16, 2024, when has been sold 9,524 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 305K
3.22% 3M change
33.51% 12M change
Total Value Held $195,516

CE RICK STRATTAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2024
BUY
Grant, award, or other acquisition
-
9,524 Added 3.02%
305,495 Common Stock
Jun 03 2024
BUY
Grant, award, or other acquisition
-
9,375 Added 3.07%
295,971 Common Stock
Feb 13 2024
BUY
Grant, award, or other acquisition
-
6,963 Added 2.37%
286,596 Common Stock
Nov 28 2023
BUY
Grant, award, or other acquisition
-
8,209 Added 2.85%
279,633 Common Stock
Oct 27 2023
BUY
Grant, award, or other acquisition
-
42,599 Added 13.57%
271,424 Common Stock
Aug 18 2023
BUY
Grant, award, or other acquisition
-
8,089 Added 3.41%
228,825 Common Stock
May 17 2023
BUY
Grant, award, or other acquisition
-
21,360 Added 8.82%
220,736 Common Stock
CRS

Ce Rick Strattan

Director
Gainesville, FL

Track Institutional and Insider Activities on CYTH

Follow Cyclo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

News

Receive news related to Cyclo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYTH